Ongoing regulatory surveillance finds drug samples did not meet quality criteria as the Central Drug Standards Control ...
Minesweeper board Junshi Biosciences Signs R&D Collaboration and License Agreement with Oncology Drug Company REVITOPE FDA rejects new antibiotic Cont ...
Coins Of Ra - Hold 130 major products volume purchases to be implemented today Jiangsu pharmaceutical companies won $500 million in antidiabetic dru ...
7h
Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.28 and traded as low ...
2-Year U.S. Treasury Note Continuous Contract $102.668 0.004 0.00% 5-Year U.S. Treasury Note Continuous Contract $106.016-0.109-0.10% 10-Year U.S. Treasury Note Continuous Contract $108.375-0.281 ...
IPC Indice de Precios Y Cotizaciones 49,290.58-245.00-0.49% ...
Experimentally determined structure of 2-nitroimidazole hydrolase and its comparison with other related enzymes shed light on the mechanism of action of an unusual antibiotic degrading enzyme in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback